article Editorial. (2015). New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation. Столичная издательская компания.
Chicago Style (17th ed.) Citationarticle Editorial. New Data of the Real Clinical Practice Confirms Low Incidence of Major Bleeding When Using Rivaroxaban in Patients with Non-valvular Atrial Fibrillation. Столичная издательская компания, 2015.
MLA (9th ed.) Citationarticle Editorial. New Data of the Real Clinical Practice Confirms Low Incidence of Major Bleeding When Using Rivaroxaban in Patients with Non-valvular Atrial Fibrillation. Столичная издательская компания, 2015.
Warning: These citations may not always be 100% accurate.